nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ALS Drug Development: Reflections from the Past and a Way Forward
|
Aggarwal, Swati |
|
2008 |
5 |
4 |
p. 516-527 12 p. |
artikel |
2 |
ALS drug development: Reflections from the past and a way forward
|
Aggarwal, Swati |
|
2008 |
5 |
4 |
p. 516-527 |
artikel |
3 |
ALS Drug Development: Reflections from the Past and a Way Forward
|
Aggarwal, Swati |
|
|
5 |
4 |
p. 516-527 |
artikel |
4 |
Approaching a New Age in Duchenne Muscular Dystrophy Treatment
|
Wagner, Kathryn R. |
|
2008 |
5 |
4 |
p. 583-591 9 p. |
artikel |
5 |
Approaching a new age in Duchenne muscular dystrophy treatment
|
Wagner, Kathryn R. |
|
2008 |
5 |
4 |
p. 583-591 |
artikel |
6 |
Approaching a New Age in Duchenne Muscular Dystrophy Treatment
|
Wagner, Kathryn R. |
|
|
5 |
4 |
p. 583-591 |
artikel |
7 |
Author Index
|
|
|
2008 |
5 |
4 |
p. 638- 1 p. |
artikel |
8 |
Author Index
|
|
|
|
5 |
4 |
p. 638 |
artikel |
9 |
Contents
|
|
|
2008 |
5 |
4 |
p. A2-A3 nvt p. |
artikel |
10 |
Contents
|
|
|
|
5 |
4 |
p. A2-A3 |
artikel |
11 |
Current and Future Standards in Treatment of Myasthenia Gravis
|
Gold, Ralf |
|
2008 |
5 |
4 |
p. 535-541 7 p. |
artikel |
12 |
Current and future standards in treatment of myasthenia gravis
|
Gold, Ralf |
|
2008 |
5 |
4 |
p. 535-541 |
artikel |
13 |
Current and Future Standards in Treatment of Myasthenia Gravis
|
Gold, Ralf |
|
|
5 |
4 |
p. 535-541 |
artikel |
14 |
Editorial Board
|
|
|
2008 |
5 |
4 |
p. A1- 1 p. |
artikel |
15 |
Editorial Board
|
|
|
|
5 |
4 |
p. A1 |
artikel |
16 |
Experimental Therapeutics in Hereditary Neuropathies: The Past, the Present, and the Future
|
Herrmann, David N. |
|
2008 |
5 |
4 |
p. 507-515 9 p. |
artikel |
17 |
Experimental therapeutics in hereditary neuropathies: The past, the present, and the future
|
Herrmann, David N. |
|
2008 |
5 |
4 |
p. 507-515 |
artikel |
18 |
Experimental Therapeutics in Hereditary Neuropathies: The Past, the Present, and the Future
|
Herrmann, David N. |
|
|
5 |
4 |
p. 507-515 |
artikel |
19 |
Facioscapulohumeral Muscular Dystrophy
|
Tawil, Rabi |
|
2008 |
5 |
4 |
p. 601-606 6 p. |
artikel |
20 |
Facioscapulohumeral muscular dystrophy
|
Tawil, Rabi |
|
2008 |
5 |
4 |
p. 601-606 |
artikel |
21 |
Facioscapulohumeral Muscular Dystrophy
|
Tawil, Rabi |
|
|
5 |
4 |
p. 601-606 |
artikel |
22 |
How Can We Treat Mitochondrial Encephalomyopathies? Approaches to Therapy
|
Horvath, Rita |
|
2008 |
5 |
4 |
p. 558-568 11 p. |
artikel |
23 |
How can we treat mitochondrial encephalomyopathies? approaches to therapy
|
Horvath, Rita |
|
2008 |
5 |
4 |
p. 558-568 |
artikel |
24 |
How Can We Treat Mitochondrial Encephalomyopathies? Approaches to Therapy
|
Horvath, Rita |
|
|
5 |
4 |
p. 558-568 |
artikel |
25 |
Idiopathic Inflammatory Myopathies: Current and Future Therapeutic Options
|
Wiendl, Heinz |
|
2008 |
5 |
4 |
p. 548-557 10 p. |
artikel |
26 |
Idiopathic inflammatory myopathies: Current and future therapeutic options
|
Wiendl, Heinz |
|
2008 |
5 |
4 |
p. 548-557 |
artikel |
27 |
Idiopathic Inflammatory Myopathies: Current and Future Therapeutic Options
|
Wiendl, Heinz |
|
|
5 |
4 |
p. 548-557 |
artikel |
28 |
Inflammatory Demyelinating Neuropathies and Neuropathies Associated with Monoclonal Gammopathies: Treatment Update
|
Steck, Andreas J. |
|
2008 |
5 |
4 |
p. 528-534 7 p. |
artikel |
29 |
Inflammatory demyelinating neuropathies and neuropathies associated with monoclonal gammopathies: Treatment update
|
Steck, Andreas J. |
|
2008 |
5 |
4 |
p. 528-534 |
artikel |
30 |
Inflammatory Demyelinating Neuropathies and Neuropathies Associated with Monoclonal Gammopathies: Treatment Update
|
Steck, Andreas J. |
|
|
5 |
4 |
p. 528-534 |
artikel |
31 |
Muscular Dystrophies Due to Glycosylation Defects
|
Muntoni, Francesco |
|
2008 |
5 |
4 |
p. 627-632 6 p. |
artikel |
32 |
Muscular dystrophies due to glycosylation defects
|
Muntoni, Francesco |
|
2008 |
5 |
4 |
p. 627-632 |
artikel |
33 |
Muscular Dystrophies Due to Glycosylation Defects
|
Muntoni, Francesco |
|
|
5 |
4 |
p. 627-632 |
artikel |
34 |
Myotonic Dystrophy: Therapeutic Strategies for the Future
|
Wheeler, Thurman M. |
|
2008 |
5 |
4 |
p. 592-600 9 p. |
artikel |
35 |
Myotonic dystrophy: Therapeutic strategies for the future
|
Wheeler, Thurman M. |
|
2008 |
5 |
4 |
p. 592-600 |
artikel |
36 |
Myotonic Dystrophy: Therapeutic Strategies for the Future
|
Wheeler, Thurman M. |
|
|
5 |
4 |
p. 592-600 |
artikel |
37 |
New Treatments for Neuromuscular Disease: Optimism and Obstacles
|
Lochmüller, Hanns |
|
2008 |
5 |
4 |
p. 497-498 2 p. |
artikel |
38 |
New treatments for neuromuscular disease: Optimism and obstacles
|
Lochmüller, Hanns |
|
2008 |
5 |
4 |
p. 497-498 |
artikel |
39 |
New Treatments for Neuromuscular Disease: Optimism and Obstacles
|
Lochmüller, Hanns |
|
|
5 |
4 |
p. 497-498 |
artikel |
40 |
Spinal Muscular Atrophy
|
Oskoui, Maryam |
|
2008 |
5 |
4 |
p. 499-506 8 p. |
artikel |
41 |
Spinal muscular atrophy
|
Oskoui, Maryam |
|
2008 |
5 |
4 |
p. 499-506 |
artikel |
42 |
Spinal Muscular Atrophy
|
Oskoui, Maryam |
|
|
5 |
4 |
p. 499-506 |
artikel |
43 |
Subject Index
|
|
|
2008 |
5 |
4 |
p. 639-642 4 p. |
artikel |
44 |
Subject Index
|
|
|
|
5 |
4 |
p. 639-642 |
artikel |
45 |
The Hereditary Inclusion Body Myopathy Enigma and its Future Therapy
|
Argov, Zohar |
|
2008 |
5 |
4 |
p. 633-637 5 p. |
artikel |
46 |
The hereditary inclusion body myopathy enigma and its future therapy
|
Argov, Zohar |
|
2008 |
5 |
4 |
p. 633-637 |
artikel |
47 |
The Hereditary Inclusion Body Myopathy Enigma and its Future Therapy
|
Argov, Zohar |
|
|
5 |
4 |
p. 633-637 |
artikel |
48 |
Therapeutic Approaches in Glycogen Storage Disease Type II/Pompe Disease
|
Schoser, Benedikt |
|
2008 |
5 |
4 |
p. 569-578 10 p. |
artikel |
49 |
Therapeutic approaches in glycogen storage disease type II/pompe disease
|
Schoser, Benedikt |
|
2008 |
5 |
4 |
p. 569-578 |
artikel |
50 |
Therapeutic Approaches in Glycogen Storage Disease Type II/Pompe Disease
|
Schoser, Benedikt |
|
|
5 |
4 |
p. 569-578 |
artikel |
51 |
Therapeutic Options in Other Metabolic Myopathies
|
Vorgerd, Matthias |
|
2008 |
5 |
4 |
p. 579-582 4 p. |
artikel |
52 |
Therapeutic options in other metabolic myopathies
|
Vorgerd, Matthias |
|
2008 |
5 |
4 |
p. 579-582 |
artikel |
53 |
Therapeutic Options in Other Metabolic Myopathies
|
Vorgerd, Matthias |
|
|
5 |
4 |
p. 579-582 |
artikel |
54 |
Therapeutic Possibilities in the Autosomal Recessive Limb-Girdle Muscular Dystrophies
|
Straub, Volker |
|
2008 |
5 |
4 |
p. 619-626 8 p. |
artikel |
55 |
Therapeutic possibilities in the autosomal recessive limb-girdle muscular dystrophies
|
Straub, Volker |
|
2008 |
5 |
4 |
p. 619-626 |
artikel |
56 |
Therapeutic Possibilities in the Autosomal Recessive Limb-Girdle Muscular Dystrophies
|
Straub, Volker |
|
|
5 |
4 |
p. 619-626 |
artikel |
57 |
Therapeutic Strategies in Congenital Myasthenic Syndromes
|
Schara, Ulrike |
|
2008 |
5 |
4 |
p. 542-547 6 p. |
artikel |
58 |
Therapeutic strategies in congenital myasthenic syndromes
|
Schara, Ulrike |
|
2008 |
5 |
4 |
p. 542-547 |
artikel |
59 |
Therapeutic Strategies in Congenital Myasthenic Syndromes
|
Schara, Ulrike |
|
|
5 |
4 |
p. 542-547 |
artikel |
60 |
Therapy of Collagen VI-Related Myopathies (Bethlem and Ullrich)
|
Merlini, Luciano |
|
2008 |
5 |
4 |
p. 613-618 6 p. |
artikel |
61 |
Therapy of collagen VI-related myopathies (Bethlem and Ullrich)
|
Merlini, Luciano |
|
2008 |
5 |
4 |
p. 613-618 |
artikel |
62 |
Therapy of Collagen VI-Related Myopathies (Bethlem and Ullrich)
|
Merlini, Luciano |
|
|
5 |
4 |
p. 613-618 |
artikel |
63 |
Treatment of Neuromuscular Channelopathies: Current Concepts and Future Prospects
|
Cleland, James C. |
|
2008 |
5 |
4 |
p. 607-612 6 p. |
artikel |
64 |
Treatment of neuromuscular channelopathies: Current concepts and future prospects
|
Cleland, James C. |
|
2008 |
5 |
4 |
p. 607-612 |
artikel |
65 |
Treatment of Neuromuscular Channelopathies: Current Concepts and Future Prospects
|
Cleland, James C. |
|
|
5 |
4 |
p. 607-612 |
artikel |